General Clinical Pharmacology Considerations for Pediatric Studies of Drugs, Including Biological Products¶
U.S. Food and Drug Administration. (2022). General Clinical Pharmacology Considerations for Pediatric Studies of Drugs, Including Biological Products.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Transferability Overclaim
- In clinical medicine it is the trial conducted in adult males used to dose children or pregnant patients, with the inclusion and exclusion criteria vanished from the prescribing label.
This sourceFrames extrapolation of adult trial findings to pediatric populations, the conditions under which it is and is not warranted, and the data needed before exporting an adult result to children.
- In clinical medicine it is the trial conducted in adult males used to dose children or pregnant patients, with the inclusion and exclusion criteria vanished from the prescribing label.
Verification¶
Does it exist? Not checked yet. This entry carries no identifier to resolve. It was extracted from the citation as written in the article, normalized, and deduplicated against the rest of the registry.
Does it back the claim? Not recorded. The single citation of this work carries no recorded support check.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:f6d02f946936 · see in the full table